How does epilepsy impact the pharmacotherapeutic management of patients with dementia with Lewy bodies?

How does epilepsy impact the pharmacotherapeutic management of patients with dementia with Lewy bodies? Expert Opin Pharmacother. 2020 Jan 03;:1-3 Authors: Cretin B, Blanc F PMID: 31899987 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31899987?dopt=Abstract

Source: Expert Opinion on Pharmacotherapy - January 6, 2020 Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research

More News: Dementia | Drugs & Pharmacology | Epilepsy